fluoxetine has been researched along with Basal Ganglia Diseases in 30 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of urinary retention emerging after fluoxetine (20 mg/day) addition to low risperidone doses (2 mg/day) is presented." | 7.71 | Urinary retention caused after fluoxetine-risperidone combination. ( Bozikas, V; Karavatos, A; Petrikis, P, 2001) |
| "A case of urinary retention emerging after fluoxetine (20 mg/day) addition to low risperidone doses (2 mg/day) is presented." | 3.71 | Urinary retention caused after fluoxetine-risperidone combination. ( Bozikas, V; Karavatos, A; Petrikis, P, 2001) |
| "We present a 15-year-old girl with depression, an obsessive compulsive disorder and conduct disorder, who developed EPS (torticollis, bradykinesia and cogwheel rigidity) while on fluoxetine." | 3.71 | Fluoxetine-induced extrapyramidal symptoms in an adolescent: a case report. ( Avci, A; Diler, RS; Yolga, AY, 2002) |
| "Fluoxetine was the only psychotropic agent used for seven of the 15 patients; two patients were also taking lithium, four were taking neuroleptics, two were taking tricyclic antidepressants, and one was taking metoclopramide." | 1.29 | Fluoxetine and extrapyramidal side effects. ( Coulter, DM; Pillans, PI, 1995) |
| "Fluoxetine (20 mg/day) was added for 7-10 days to stable doses of haloperidol given to eight psychotic patients." | 1.28 | Elevation of plasma concentrations of haloperidol after the addition of fluoxetine. ( Baldessarini, RJ; Brotman, AW; Goff, DC; Midha, KK; Waites, M, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.00) | 18.7374 |
| 1990's | 21 (70.00) | 18.2507 |
| 2000's | 5 (16.67) | 29.6817 |
| 2010's | 1 (3.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, MY | 1 |
| Etminan, M | 1 |
| Procyshyn, RM | 1 |
| Kim, DD | 1 |
| Samii, A | 1 |
| Kezouh, A | 1 |
| Carleton, BC | 1 |
| Caixeta, L | 1 |
| Coulter, DM | 1 |
| Pillans, PI | 1 |
| Singh, RK | 1 |
| Gupta, AK | 1 |
| Singh, B | 1 |
| Dave, M | 1 |
| Muly, EC | 1 |
| McDonald, W | 1 |
| Steffens, D | 1 |
| Book, S | 1 |
| Ketai, R | 1 |
| Hesselink, JM | 1 |
| Fishbain, DA | 1 |
| Daniel, DG | 1 |
| Smith, K | 1 |
| Hyde, T | 1 |
| Egan, M | 1 |
| Pies, R | 1 |
| Arya, DK | 1 |
| Posada, IJ | 1 |
| López-Valdés, E | 1 |
| Vallejo, AR | 1 |
| Portera, A | 1 |
| Shelton, RC | 1 |
| Tollefson, GD | 1 |
| Tohen, M | 1 |
| Stahl, S | 1 |
| Gannon, KS | 1 |
| Jacobs, TG | 1 |
| Buras, WR | 1 |
| Bymaster, FP | 1 |
| Zhang, W | 1 |
| Spencer, KA | 1 |
| Feldman, PD | 1 |
| Meltzer, HY | 1 |
| Bozikas, V | 1 |
| Petrikis, P | 1 |
| Karavatos, A | 1 |
| Diler, RS | 1 |
| Yolga, AY | 1 |
| Avci, A | 1 |
| Hamilton, MS | 1 |
| Opler, LA | 1 |
| Pach, J | 1 |
| Pearlman, T | 1 |
| Stoukides, JA | 1 |
| Stoukides, CA | 1 |
| Budman, CL | 1 |
| Bruun, RD | 1 |
| Baldwin, D | 1 |
| Fineberg, N | 1 |
| Montgomery, S | 1 |
| Sternbach, H | 1 |
| Goff, DC | 1 |
| Midha, KK | 1 |
| Brotman, AW | 1 |
| Waites, M | 1 |
| Baldessarini, RJ | 1 |
| Fallon, BA | 1 |
| Liebowitz, MR | 1 |
| Reccoppa, L | 1 |
| Welch, WA | 1 |
| Ware, MR | 1 |
| Figiel, GS | 1 |
| Krishnan, KR | 1 |
| Breitner, JC | 1 |
| Nemeroff, CB | 1 |
| Tate, JL | 1 |
2 reviews available for fluoxetine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Akathisia, suicidality, and fluoxetine.
Topics: Akathisia, Drug-Induced; Basal Ganglia Diseases; Depression; Fluoxetine; Humans; Models, Neurologica | 1992 |
The serotonin syndrome.
Topics: Adult; Antidepressive Agents; Basal Ganglia Diseases; Depressive Disorder; Drug Interactions; Drug T | 1991 |
1 trial available for fluoxetine and Basal Ganglia Diseases
| Article | Year |
|---|---|
A novel augmentation strategy for treating resistant major depression.
Topics: Ambulatory Care; Basal Ganglia Diseases; Benzodiazepines; Depressive Disorder; Double-Blind Method; | 2001 |
27 other studies available for fluoxetine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxeti | 2018 |
Fluoxetine associated with severe extrapyramidal symptoms in a patient with basal ganglia lesion.
Topics: Basal Ganglia Diseases; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibi | 2009 |
Antidepressants and extrapyramidal effects.
Topics: Antidepressive Agents; Antipsychotic Agents; Basal Ganglia Diseases; Fluoxetine; Humans; Selective S | 2003 |
Fluoxetine and extrapyramidal side effects.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Antidepressive Agents, Tricyclic; Antipsychoti | 1995 |
Acute organic brain syndrome after fluoxetine treatment.
Topics: Aged; Basal Ganglia Diseases; Delirium; Depressive Disorder; Dose-Response Relationship, Drug; Drug | 1995 |
Fluoxetine-associated dystonia.
Topics: Basal Ganglia Diseases; Depressive Disorder; Dystonia; Female; Fluoxetine; Humans; Middle Aged | 1994 |
Serotonin syndrome produced by a combination of fluoxetine and lithium.
Topics: Adult; Basal Ganglia Diseases; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; H | 1993 |
Interaction between fluoxetine and neuroleptics.
Topics: Akathisia, Drug-Induced; Basal Ganglia Diseases; Drug Interactions; Fluoxetine; Fluphenazine; Humans | 1993 |
Serotonin and Parkinson's disease.
Topics: Basal Ganglia Diseases; Depressive Disorder; Dopamine; Drug Therapy, Combination; Fluoxetine; Humans | 1993 |
Fluoxetine and extrapyramidal side effects.
Topics: Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Selective Serotonin Reuptake I | 1996 |
Neuroleptic-induced tardive dyskinesia.
Topics: Adolescent; Basal Ganglia Diseases; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluoxetine; | 1996 |
Re: Extrapyramidal side effects with low-dose risperidone.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Drug Interactions; F | 1997 |
Existing brain condition may predispose to SSRI-induced extrapyramidal symptoms.
Topics: Akathisia, Drug-Induced; Basal Ganglia Diseases; Bipolar Disorder; Cerebral Infarction; Female; Fluo | 1997 |
Extrapyramidal side effects and serotonin syndrome with fluoxetine and biperiden.
Topics: Aged; Basal Ganglia Diseases; Biperiden; Depression; Fluoxetine; Humans; Male; Parasympatholytics; S | 1998 |
Urinary retention caused after fluoxetine-risperidone combination.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Basal Ganglia Diseases; Delusions; D | 2001 |
Fluoxetine-induced extrapyramidal symptoms in an adolescent: a case report.
Topics: Adolescent; Basal Ganglia Diseases; Conduct Disorder; Depression; Drug Hypersensitivity; Female; Flu | 2002 |
[Pharmacotoxic psychosis and extrapyramidal motor syndrome. A case of acute adverse effect of fluoxetine and flupenthixol].
Topics: Adult; Basal Ganglia Diseases; Female; Fluoxetine; Flupenthixol; Humans; Neurologic Examination; Obs | 1992 |
Fluoxetine and suicidality.
Topics: Akathisia, Drug-Induced; Anxiety Disorders; Basal Ganglia Diseases; Depressive Disorder; Dose-Respon | 1992 |
Extrapyramidal symptoms upon discontinuation of fluoxetine.
Topics: Adult; Basal Ganglia Diseases; Depressive Disorder; Dystonia; Fluoxetine; Humans; Male; Substance Wi | 1991 |
Persistent dyskinesia in a patient receiving fluoxetine.
Topics: Adult; Basal Ganglia Diseases; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Fluoxetine; Hu | 1991 |
Fluoxetine, fluvoxamine and extrapyramidal tract disorders.
Topics: Adult; Basal Ganglia Diseases; Female; Fluoxetine; Fluvoxamine; Humans; Mental Disorders; Middle Age | 1991 |
Elevation of plasma concentrations of haloperidol after the addition of fluoxetine.
Topics: Adult; Aged; Basal Ganglia Diseases; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetin | 1991 |
Fluoxetine and extrapyramidal symptoms in CNS lupus.
Topics: Adult; Basal Ganglia Diseases; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Fluoxetine; Hu | 1991 |
Acute dystonia and fluoxetine.
Topics: Acute Disease; Adult; Basal Ganglia Diseases; Depressive Disorder; Dystonia; Female; Fluoxetine; Hum | 1990 |
Radiologic correlates of antidepressant-induced delirium: the possible significance of basal-ganglia lesions.
Topics: Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Basal Ganglia; Basal Ganglia Diseases | 1989 |
Fluoxetine and extrapyramidal side effects.
Topics: Adult; Basal Ganglia Diseases; Depressive Disorder; Female; Fluoxetine; Humans; Middle Aged; Parkins | 1989 |
Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine.
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Femal | 1989 |